PLRX Pliant Therapeutics, Inc. - Common Stock
$1.19
价格 · 八月 19, 2026
截至...的财报数据 八月 11, 2026
52周区间
$1–$2
18% of range
分析师评级
HOLD
10 analysts
目标价
$2
+111% upside
P/E (TTM)
-0.5
ROE
-74.4%
净利润率
—
关于 Pliant Therapeutics, Inc. - Common Stock 公司概况（来自维基百科）
PLRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.19
市值
$73M
P/E (TTM)
-0.5
每股收益 (TTM)
$-2.43
营收 (TTM)
$0
股息收益率
—
ROE
-74.4%
负债/权益
—
52周区间
$1 – $2
PLRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2019-12-31
→
2025-12-31
EPS
$-2.43
2019-12-31
→
2025-12-31
自由现金流
$-129M
2020-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
PLRX
同行中位数
P/E (TTM)
-0.5
44.2
P/B (市净率)
0.4
3.1
Price / FCF (股价/自由现金流)
-0.6
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
PLRX
同行中位数
ROA
-48.0%
-54.4%
ROE
-74.4%
-87.0%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
PLRX
同行中位数
Current Ratio (流动比率)
12.0
2.0
Quick Ratio (速动比率)
11.7
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
PLRX
同行中位数
Revenue YoY (营收同比增长)
-83.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
-66.4%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
PLRX
同行中位数
PLRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
卖出
10 位分析师
- 强烈买入 0 0.0%
- 买入 0 0.0%
- 持有 6 60.0%
- 卖出 2 20.0%
- 强烈卖出 2 20.0%
12个月价格目标
2 位分析师 · 2026-08-16
中位数
$2.50
← 低于所有目标
$1.19
最低
$2.00
最高
$3.00
中位数目标
$2.50
+111.0%
平均目标
$2.50
+111.0%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年3月31日 | $-0.32 | $-0.36 | 0.04% |
| 2025年12月31日 | $-0.38 | $-0.39 | 0.01% |
| 2025年9月30日 | $-0.43 | $-0.53 | 0.10% |
| 2025年6月30日 | $-0.71 | $-0.71 | -0.00% |
| 2025年3月31日 | $-0.92 | $-0.74 | -0.18% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PLRX | $75M | -0.5 | -83.7% | — | -74.4% | — |
| LONA | $71M | -0.3 | — | — | -353.4% | — |
| CING | — | — | — | — | — | — |
| ELOX | — | — | — | — | 30.1% | — |
| TELO | $46M | -4.0 | — | — | -325.7% | — |
| IMA | — | -0.7 | -77.1% | -5668.6% | 192.1% | — |
| TLPH | $56M | — | — | -51035.7% | -120.8% | — |
| BSEM | — | — | — | — | — | — |
| SCLX | — | — | — | — | — | — |
| SCYX | $28M | -3.7 | 450.0% | -41.8% | -18.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $2M | $10M | $8M | $42M | $57M | |
| R&D Expense | $109M | $169M | $128M | $97M | $78M | $66M | $47M | |
| SG&A Expense | $47M | $59M | $58M | $40M | $28M | $17M | $11M | |
| Operating Expenses | $156M | $228M | $186M | $137M | $105M | $83M | $58M | |
| Operating Income | $-156M | $-228M | $-184M | $-127M | $-98M | $-42M | $-1M | |
| Interest Expense | · | · | $1M | $791.0K | $0 | · | · | |
| Interest Income | · | · | · | · | · | $478.0K | $816.0K | |
| Other Non-op | · | · | · | · | · | $-366.0K | $-216.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | $-631.0K | |
| EPS (Basic) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| EPS (Diluted) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 | $-1.95 | $-4.22 | |
| Shares (Basic) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| Shares (Diluted) | 61,366,887 | 60,538,639 | 58,719,083 | 42,015,908 | 35,846,421 | 21,344,236 | 1,623,358 | |
| EBITDA | $-156M | $-228M | $-184M | $-127M | · | $-42M | · |
资产负债表 23
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $71M | $63M | $34M | $52M | $51M | $86M | |
| Short-term Investments | $145M | $285M | $431M | $298M | $149M | $226M | $17M | |
| Receivables | · | · | $0 | $2M | $2M | $9M | $7M | |
| Prepaid Expense | $4M | $7M | $11M | $7M | $7M | $4M | $2M | |
| Current Assets | $196M | $362M | $506M | $340M | $209M | $291M | $112M | |
| PP&E (Net) | $3M | $6M | $4M | $4M | $5M | $4M | $4M | |
| PP&E (Gross) | $14M | $16M | $12M | $11M | $10M | $8M | $6M | |
| Accum. Depreciation | $11M | $11M | $9M | $7M | $5M | $3M | $2M | |
| Other Non-current Assets | $392.0K | $435.0K | $392.0K | $394.0K | $838.0K | $451.0K | $3M | |
| Total Assets | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Accounts Payable | $480.0K | $6M | $5M | $2M | $3M | $2M | $1M | |
| Accrued Liabilities | $10M | $12M | $10M | $9M | $12M | $10M | $7M | |
| Current Liabilities | $16M | $33M | $29M | $24M | $17M | $12M | $8M | |
| Capital Leases | $28M | $29M | $0 | $3M | $5M | $0 | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $866.0K | $912.0K | |
| Total Liabilities | $44M | $93M | $39M | $37M | $22M | $12M | $9M | |
| Long-term Debt | $0 | $30M | $10M | $10M | $0 | · | · | |
| Common Stock | $6.0K | $6.0K | $6.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-859M | $-710M | $-500M | $-338M | $-215M | $-118M | $-76M | |
| AOCI | $-15.0K | $321.0K | $345.0K | $-2M | $-201.0K | $-32.0K | $-1.0K | |
| Stockholders' Equity | $181M | $304M | $474M | $313M | $199M | $283M | $-76M | |
| Liabilities + Equity | $225M | $397M | $512M | $351M | $221M | $296M | $119M | |
| Shares Outstanding | 61,449,290 | 60,860,838 | 59,921,002 | 48,941,254 | 36,083,301 | 35,552,795 | 1,846,024 |
现金流 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $26M | $38M | $44M | $23M | $10M | $4M | $2M | |
| Operating Cash Flow | $-128M | $-156M | $-116M | $-95M | $-75M | $-37M | $-3M | |
| CapEx | $374.0K | $4M | $921.0K | $2M | $2M | $2M | $964.0K | |
| Investing Cash Flow | $134M | $140M | $-127M | $-150M | $74M | $-211M | $-18M | |
| Financing Cash Flow | $-32M | $23M | $274M | $227M | $3M | $213M | $46M | |
| Net Change in Cash | $-26M | $8M | $31M | $-18M | $783.0K | $-35M | $25M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | |
| Free Cash Flow | $-129M | $-159M | $-117M | $-96M | · | $-39M | · |
盈利能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| Net Margin | · | · | -10211.1% | -1273.3% | · | -99.3% | · | |
| EBITDA Margin | · | · | -11654.8% | -1313.4% | · | -99.6% | · | |
| ROA | -48.0% | -46.3% | -37.4% | -43.1% | · | -20.0% | · | |
| ROE | -74.4% | -64.7% | -33.0% | -37.9% | · | -14.2% | · |
流动性与偿付能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 10.9 | 17.7 | 14.2 | · | 25.1 | · | |
| Quick Ratio | 11.7 | 10.7 | 17.3 | 13.9 | · | 24.7 | · | |
| Interest Coverage | · | · | -145.3 | · | · | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | · | |
| Receivables Turnover | · | · | 1.6 | 4.9 | · | 5.1 | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -83.7% | 27.9% | -81.9% | · | · | |
| Revenue CAGR 3Y | · | · | -66.4% | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $2M | $10M | $8M | $42M | · | |
| Net Income TTM | $-149M | $-210M | $-161M | $-123M | $-97M | $-42M | · | |
| Market Cap | $75M | $802M | $1.09B | $946M | · | $808M | · | |
| P/E | -0.5 | -3.8 | -6.6 | -6.6 | -5.0 | -11.7 | · | |
| P/S | · | · | 686.8 | 97.7 | · | 19.3 | · | |
| P/B | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Tangible Book | 0.4 | 2.6 | 2.3 | 3.0 | · | 2.9 | · | |
| P / Cash Flow | -0.6 | -5.2 | -9.3 | -10.0 | · | -21.7 | · | |
| P / FCF | -0.6 | -5.0 | -9.3 | -9.8 | · | -20.8 | · | |
| Earnings Yield | -199.2% | -26.4% | -15.2% | -15.2% | -20.1% | -8.6% | · |
损益表 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $248.0K | $1M | $2M | $1M | |
| R&D Expense | $17M | $14M | $16M | $18M | $32M | $43M | $39M | $48M | $46M | $37M | $33M | $32M | $33M | $29M | $25M | $25M | |
| SG&A Expense | $7M | $8M | $8M | $10M | $13M | $15M | $15M | $14M | $15M | $15M | $14M | $15M | $15M | $14M | $14M | $9M | |
| Operating Expenses | $24M | $22M | $24M | $28M | $46M | $59M | $53M | $62M | $61M | $52M | $47M | $48M | $48M | $43M | $39M | $33M | |
| Operating Income | $-24M | $-22M | $-24M | $-28M | $-46M | $-59M | $-53M | $-62M | $-61M | $-52M | $-47M | $-48M | $-47M | $-42M | $-37M | $-32M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $445.0K | · | $317.0K | $319.0K | $311.0K | · | $301.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-22M | $-20M | $-24M | $-26M | $-43M | $-56M | $-50M | $-58M | $-56M | $-47M | $-41M | $-41M | $-41M | $-38M | $-35M | $-31M | |
| EPS (Basic) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.69 | $-0.65 | |
| EPS (Diluted) | $-0.36 | $-0.32 | $-0.37 | $-0.43 | $-0.71 | $-0.92 | $-0.82 | $-0.95 | $-0.92 | $-0.78 | $-0.68 | $-0.70 | $-0.70 | $-0.67 | $-0.69 | $-0.65 | |
| Shares (Basic) | 61,919,233 | 61,803,467 | -122,648,447 | 61,406,475 | 61,386,183 | 61,222,676 | -120,756,013 | 60,730,935 | 60,382,796 | 60,180,921 | -116,199,840 | 59,688,451 | 59,172,869 | 56,057,603 | -77,072,725 | 46,799,058 | |
| Shares (Diluted) | 61,919,233 | 61,803,467 | -122,648,447 | 61,406,475 | 61,386,183 | 61,222,676 | -120,756,013 | 60,730,935 | 60,382,796 | 60,180,921 | -116,199,840 | 59,688,451 | 59,172,869 | 56,057,603 | -77,072,725 | 46,799,058 | |
| EBITDA | $-24M | $-22M | · | $-28M | $-46M | $-59M | · | $-62M | $-61M | $-52M | · | $-48M | $-47M | $-42M | · | $-32M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $22M | $45M | $94M | $87M | $92M | $71M | $80M | $80M | $114M | $63M | $58M | $55M | $103M | · | $45M | |
| Short-term Investments | $133M | $149M | $145M | $148M | $176M | $214M | $285M | $325M | $356M | $368M | $431M | $466M | $500M | $475M | · | $316M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $3M | · | $1M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $5M | $6M | $7M | $6M | $11M | $8M | $11M | $11M | $9M | $8M | · | $4M | |
| Current Assets | $163M | $175M | $196M | $246M | $267M | $311M | $362M | $410M | $448M | $490M | $506M | $534M | $566M | $588M | · | $366M | |
| PP&E (Net) | $2M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | $5M | $6M | $4M | $4M | $4M | $4M | · | $5M | |
| PP&E (Gross) | $13M | $13M | $14M | $16M | $17M | $16M | $16M | $16M | $15M | $15M | $12M | $12M | $12M | $11M | · | $11M | |
| Accum. Depreciation | $11M | $10M | $11M | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | · | $6M | |
| Other Non-current Assets | $554.0K | $389.0K | $392.0K | $392.0K | $391.0K | $427.0K | $435.0K | $427.0K | $437.0K | $392.0K | $392.0K | $392.0K | $672.0K | $644.0K | · | $397.0K | |
| Total Assets | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | · | $377M | |
| Accounts Payable | $2M | $362.0K | $480.0K | $485.0K | $1M | $6M | $6M | $7M | $3M | $7M | $5M | $3M | $2M | $1M | · | $3M | |
| Accrued Liabilities | $4M | $4M | $10M | $8M | $7M | $7M | $12M | $10M | $8M | $6M | $10M | $8M | $7M | · | · | $20M | |
| Current Liabilities | $16M | $10M | $16M | $18M | $21M | $28M | $33M | $40M | $31M | $30M | $29M | $27M | $30M | $23M | · | $26M | |
| Capital Leases | $26M | $27M | $28M | $28M | $29M | $29M | $29M | $30M | $30M | $24M | $0 | $0 | $2M | $3M | · | $4M | |
| Total Liabilities | $43M | $37M | $44M | $76M | $80M | $88M | $93M | $100M | $91M | $84M | $39M | $37M | $42M | $36M | · | $40M | |
| Long-term Debt | $0 | $0 | $0 | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $10M | $10M | $10M | $10M | · | $10M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | |
| Retained Earnings | $-902M | $-879M | $-859M | $-836M | $-810M | $-766M | $-710M | $-660M | $-603M | $-547M | $-500M | $-459M | $-417M | $-376M | · | $-303M | |
| AOCI | $-397.0K | $-341.0K | $-15.0K | $34.0K | $-1.0K | $159.0K | $321.0K | $848.0K | $-617.0K | $-489.0K | $345.0K | $-2M | $-2M | $-1M | · | $-2M | |
| Stockholders' Equity | $147M | $165M | $181M | $200M | $220M | $257M | $304M | $346M | $393M | $437M | $474M | $503M | $533M | $562M | $313M | $337M | |
| Liabilities + Equity | $190M | $203M | $225M | $277M | $300M | $345M | $397M | $446M | $484M | $522M | $512M | $540M | $575M | $598M | · | $377M | |
| Shares Outstanding | 61,920,154 | 61,914,569 | 61,449,290 | 61,449,290 | 61,386,183 | 61,386,183 | 60,860,838 | 60,849,503 | 60,425,144 | 60,318,542 | 59,921,002 | 59,890,980 | 59,222,685 | 58,978,902 | 48,941,254 | 48,749,842 |
现金流 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $4M | $5M | $6M | $6M | $9M | $8M | $9M | $11M | $10M | $9M | $10M | $13M | $12M | $11M | $5M | |
| Operating Cash Flow | $-13M | $-19M | $-18M | $-21M | $-41M | $-49M | $-48M | $-32M | $-45M | $-30M | $-25M | $-36M | $-25M | $-30M | $-31M | $-18M | |
| CapEx | $0 | $0 | $0 | $0 | $112.0K | $262.0K | $209.0K | $896.0K | $1M | $1M | $61.0K | $94.0K | $603.0K | $163.0K | $166.0K | $696.0K | |
| Investing Cash Flow | $15M | $-4M | $2M | $28M | $35M | $69M | $39M | $31M | $11M | $60M | $32M | $38M | $-23M | $-174M | $20M | $-178M | |
| Financing Cash Flow | $0 | $74.0K | $-32M | $72.0K | $0 | $498.0K | $102.0K | $543.0K | $684.0K | $22M | $219.0K | $699.0K | $161.0K | $273M | $284.0K | $216M | |
| Net Change in Cash | $3M | $-23M | $-48M | $7M | $-5M | $21M | $-8M | $-770.0K | $-34M | $51M | $7M | $3M | $-48M | $69M | $-11M | $20M | |
| Free Cash Flow | · | $-19M | · | · | · | $-49M | · | · | · | $-32M | · | · | · | $-30M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | · | -2155.7% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | -16609.7% | -2818.9% | · | -2065.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | -19083.9% | -3160.3% | · | -2155.7% | |
| ROA | -9.1% | -7.3% | · | -7.3% | -11.1% | -13.0% | · | -11.7% | -10.5% | -8.4% | · | -9.0% | -10.8% | -9.4% | · | -10.0% | |
| ROE | -12.2% | -9.5% | · | -9.6% | -14.1% | -16.2% | · | -13.6% | -12.1% | -9.4% | · | -9.9% | -12.1% | -10.2% | · | -11.0% |
流动性与偿付能力 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.9 | 16.9 | · | 13.9 | 13.0 | 11.0 | · | 10.3 | 14.5 | 16.1 | · | 19.5 | 19.2 | 25.4 | · | 14.0 | |
| Quick Ratio | 9.6 | 16.5 | · | 13.7 | 12.8 | 10.8 | · | 10.1 | 14.1 | 15.9 | · | 19.1 | 18.9 | 25.1 | · | 13.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -117.7 | · | -150.4 | -148.4 | -135.4 | · | · |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.6 | · | 1.0 |
估值 (TTM) 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $248.0K | $2M | · | $3M | $8M | $9M | · | $9M | |
| Net Income TTM | $-112M | $-146M | · | $-184M | $-213M | $-217M | · | $-202M | $-185M | $-167M | · | $-151M | $-139M | $-126M | · | $-115M | |
| Market Cap | $71M | $78M | · | $91M | $71M | $83M | · | $682M | $650M | $899M | · | $1.04B | $1.07B | $1.57B | · | $1.02B | |
| P/E | -0.6 | -0.5 | · | -0.5 | -0.3 | -0.4 | · | -3.3 | -3.5 | -5.2 | · | -6.4 | -6.4 | -9.1 | · | -7.0 | |
| P/S | · | · | · | · | · | · | · | · | 2619.2 | 568.8 | · | 339.2 | 133.3 | 173.3 | · | 109.2 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | · | 3.0 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.3 | · | 2.0 | 1.7 | 2.1 | · | 2.1 | 2.0 | 2.8 | · | 3.0 | |
| P / Cash Flow | · | -4.1 | · | · | · | -1.7 | · | · | · | -29.7 | · | · | · | -51.8 | · | · | |
| P / FCF | · | -4.1 | · | · | · | -1.7 | · | · | · | -28.3 | · | · | · | -51.5 | · | · | |
| Earnings Yield | -159.7% | -188.9% | · | -203.4% | -301.7% | -264.4% | · | -29.9% | -28.8% | -19.1% | · | -15.7% | -15.7% | -11.0% | · | -14.4% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $2M | $10M | $8M |
| 营业利润率 % | — | — | -11654.8% | -1313.4% | — |
| 净收入 | $-149M | $-210M | $-161M | $-123M | $-97M |
| 稀释后每股收益 (EPS) | $-2.43 | $-3.47 | $-2.75 | $-2.94 | $-2.71 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 12.0 | 10.9 | 17.7 | 14.2 | — |
| 速动比率 | 11.7 | 10.7 | 17.3 | 13.9 | — |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-129M | $-159M | $-117M | $-96M | — |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 101 家申报者 · $54.3M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 16 (+6 与上一季度对比) | 12 (-1 与上一季度对比) | 16 (-9 与上一季度对比) | 23 (-1 与上一季度对比) | +1.8M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 21 位内幕人士 · 7 位高管 · 13 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Bernard Coulie | President and CEO | 2023年7月17日 S | 342103 | 0 | 0 | $0 |
| Keith Lamont Cummings | Chief Financial Officer | 2023年7月17日 S | 203999 | 0 | 0 | $0 |
| Hans Hull | Chief Business Officer | 2023年8月4日 M | 194855 | 0 | 0 | $0 |
| Mike Ouimette | General Counsel & Corp. Sec'y | 2023年7月20日 S | 60443 | 0 | 0 | $0 |
| Eric Lefebvre | Chief Medical Officer | 2023年7月17日 S | 167215 | 0 | 0 | $0 |
| Lily Cheung | Chief Human Resource Officer | 2023年1月19日 A | — | 0 | 0 | $0 |
| Barbara Howes | Chief Human Resource Officer | 2021年1月23日 A | 24799 | 0 | 0 | $0 |
| Flavia Borellini | 董事 | 2026年7月9日 A | — | 0 | 0 | $0 |
| Robert Iannone | 董事 | 2026年7月9日 A | — | 0 | 0 | $0 |
| Steve E. Krognes | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Darren S Cline | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| John T Curnutte | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Thomas A Mccourt | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Hoyoung Huh | 董事 | 2026年6月11日 A | 239619 | 0 | 0 | $0 |
| Gayle A Crowell | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Smital Shah | 董事 | 2023年6月7日 A | — | 0 | 0 | $0 |
| Katharine Knobil | 董事 | 2023年6月7日 A | — | 0 | 0 | $0 |
| Suzanne Louise Bruhn | 董事 | 2023年6月7日 A | — | 0 | 0 | $0 |
| David E I Pyott | 董事 | 2023年6月7日 A | — | 0 | 0 | $0 |
| Neil Exter | — | 2021年6月29日 A | 0 | 0 | 0 | $0 |
| Charles J Homcy | — | 2021年6月29日 A | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC, KEVIN TANG, TANG CAPITAL PARTNERS, LP, TANG CAPITAL PARTNERS INTERNATIONAL, LP, TANG CAPITAL PARTNERS III, INC, TANG CAPITAL PARTNERS IV, INC, CONCENTRA BIOSCIENCES, LLC | 2025年3月10日 | 9.60% | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 5 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.01% | 206605 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.00% | 104218 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 615799 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1746470 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.00% | 153712 SH | 2026年8月8日 | 每日 |